SILGAN HOLDINGS INC (SLGN)       54.639  -0.2 (-0.37%)

54.639  -0.2 (-0.37%)

US8270481091 - Common Stock


Fundamental Rating

4

Taking everything into account, SLGN scores 4 out of 10 in our fundamental rating. SLGN was compared to 27 industry peers in the Containers & Packaging industry. SLGN has a medium financial health rating, its profitability is only medium as well. While showing a medium growth rate, SLGN is valued expensive at the moment.




Profitability

Profitability Rating

4

SLGN has a very good Piotroski-F score of 9.00. This indicates a great health and profitability for SLGN.
SLGN has a Return On Assets of 4.64%. This is comparable to the industry average of 5.91%.

SLGN has a Return On Equity of 19.84%. This is below the industry average of 21.18%.
SLGN's Profit Margin of 5.32% is worse than the rest of the industry. The industry average Profit Margin is 5.93%.
VS Industry

ROA (4.64%) VS Industry: 42% outperformed.

1.94
9.84

ROE (19.84%) VS Industry: 38% outperformed.

5.08
264.99

Profit Margin (5.32%) VS Industry: 36% outperformed.

2.25
12.05

Valuation

Valuation Rating

3

With a Price/Earnings Ratio of 13.76, SLGN is valued correctly.
Compared to an average industry Price/Earning Ratio of 12.80, SLGN is valued in line with its industry peers.
The Forward Price/Earnings Ratio of 13.00 indicates a correct valuation of SLGN.
When comparing the current price to the book value of SLGN, we can conclude it is valued correctly. It is trading at 3.50 times its book value.

Compared to an average industry Enterprise Value to EBITDA ratio of 9.39, SLGN is valued in line with its industry peers.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates SLGN does not grow enough to justify the current Price/Earnings ratio.
Compared to an average industry price book ratio of 2.65, SLGN is valued more expensive than its industry peers.
VS Industry

Price/Earnings (13.76) VS Industry: 43% outperformed.

156.83
6.44

Price/Book (3.5) VS Industry: 36% outperformed.

35.84
0.49

Enterprise Value/ EBITDA (9.4) VS Industry: 43% outperformed.

26.56
5.29

Growth

Growth Rating

4

SLGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.42%, which is quite good.
Measured over the past 5 years, SLGN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.34% on average per year.
The Revenue has grown by 12.94% in the past year. This is quite good.
SLGN is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 6.89% yearly.

The Revenue has been growing slightly by 9.41% on average over the past 5 years.
SLGN is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 0.85% yearly.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS19.34% 22.68% 16.42% 5.84% 6.27% 5.93% 6.89%
Revenue9.41% 12.61% 12.94% 1.55% 1.29% 1.9% 0.85%

Health

Health Rating

4

SLGN has a very good Piotroski-F score of 9.00. This indicates a great health and profitability for SLGN.
A Current Ratio of 1.57 indicates that SLGN should not have too much problems paying its short term obligations.
The Current Ratio is in line with the industry averages, which is at 1.56.

SLGN has a Quick Ratio of 1.00. This is a normal value and indicates that SLGN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick Ratio is in line with the industry averages, which is at 1.04.
When comparing the Debt to Equity Ratio of SLGN to the average industry Debt to Equity Ratio of 1.22, SLGN required more debt to finance its operations than its industry peers.
VS Industry

Debt/Equity (1.99) VS Industry: 32% outperformed.

14.83
0.00

Quick Ratio (1) VS Industry: 44% outperformed.

0.47
11.38

Current Ratio (1.57) VS Industry: 56% outperformed.

0.78
11.68

Dividend

Dividend Rating

5

The dividend of SLGN is nicely growing with an annual growth rate of 11.87%!
SLGN pays out 21.09% of its income as dividend. This is a sustainable payout ratio.
SLGN has been paying a dividend for at least 10 years, so it has a reliable track record.
With a Yearly Dividend Yield of 1.25%, SLGN has a reasonable but not impressive dividend return.

With a Dividend Yield of 1.25, SLGN pays less dividend than the industry average, which is at 1.77. 85% of the companies listed in the same industry pay a better dividend than SLGN!
With a Dividend Yield of 1.25, SLGN pays less dividend than the S&P500 average, which is at 2.41.
The dividend of SLGN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
VS Industry

Dividend Yield (1.25%) VS Industry: 15% outperformed.

0.29
8.32

SILGAN HOLDINGS INC54.639

NYSE:SLGN (2/6/2023, 12:21:25 PM)-0.2 (-0.37%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Containers & Packaging
Earnings (Last) 01-24 2023-01-24/amc Earnings (Next) 04-25 2023-04-25/amc
Inst Owners 66.26% Inst Owner Change -1.78%
Ins Owners 9.69% Ins Owner Change -0.46%
Market Cap 6.01B Analysts 76.84
Price Target 56.7 (3.77%)

Dividend
Industry RankSector Rank
Dividend Yield 1.25%
Dividend Growth(5Y) 11.87% DP 21.09%
Div Incr Years 11 Div Non Decr Years 11
Ex-Date N/A

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 1.26%
Min EPS beat(2) 0.45% Max EPS beat(2) 2.07%
EPS beat(4) 4 Avg EPS beat(4) 3.32%
Min EPS beat(4) 0.4% Max EPS beat(4) 10.36%
Revenue beat(2) 1 Avg Revenue beat(2) -0.71%
Min Revenue beat(2) -7.24% Max Revenue beat(2) 5.82%
Revenue beat(4) 2 Avg Revenue beat(4) -0.9%
Min Revenue beat(4) -7.24% Max Revenue beat(4) 5.82%
PT rev (1m) 4.57% PT rev (3m) 9.52%
EPS NQ rev (1m) -4.28% EPS NQ rev (3m) -4.71%
EPS NY rev (1m) 0% EPS NY rev (3m) -1.54%
Revenue NQ rev (1m) -2.24% Revenue NQ rev (3m) -2.43%
Revenue NY rev (1m) 0% Revenue NY rev (3m) 0.53%

Valuation
Industry RankSector Rank
PE 13.76
Fwd PE 13
P/S 0.94
P/FCF 11.29
P/OCF 8.04
P/B 3.5
P/tB 3.5
EV/EBITDA 9.4
EPS(TTM) 3.97 EY 7.27%
EPS(NY) 4.2 Fwd EY 7.69%
FCF(TTM) 4.84 FCFY 8.86%
OCF(TTM) 6.8 OCFY 12.44%
SpS 58.24 BVpS 15.61
TBVpS 15.61 PEG (NY) 2.36
PEG (5Y) 0.71

Profitability
Industry RankSector Rank
ROA 4.64%
ROE 19.84%
ROIC 8.4%
ROICexc 9.31%
ROICexgc 9.31%
OM 10.54%
PM 5.32%
GM 16.34%
ROICexgc(3y) 13.83% ROICexcg growth 3Y -12.68%
ROICexcg growth 5Y -7.96% ROICexc(3y) 8.5%
ROICexc growth 3Y 3.73% ROICexc growth 5Y 3.25%
OM growth 3Y 4.42% OM growth 5Y 2.16%
PM growth 3Y 7.19% PM growth 5Y -4.22%
GM growth 3Y 0.93% GM growth 5Y 1.05%
F-Score 9 Asset Turnover 0.87

Health
Industry RankSector Rank
Debt/Equity 1.99
Debt/FCF 6.43
Debt/EBITDA 3.63
Cap/Depr 80.46%
Profit Quality 156.26%
Current Ratio 1.57
Quick Ratio 1
Altman-Z N/A
F-Score 9 WACC 6.64%
ROIC/WACC 1.4 Cap/Depr(3y) 91.85%
Cap/Depr(5y) 97.4% Profit Quality(3y) 123.07%
Profit Quality(5y) 130.55%

Growth
EPS 1Y 16.42% EPS 3Y 22.68%
EPS 5Y 19.34% EPS growth Q2Q 6.33%
EPS Next Y 5.84% EPS Next 2Y 6.27%
EPS Next 3Y 5.93% EPS Next 5Y 6.89%
Revenue growth 1Y 12.94% Revenue growth 3Y 12.61%
Revenue growth 5Y 9.41% Revenue growth Q2Q 1.12%
Revenue Next Year 1.55% Revenue Next 2Y 1.29%
Revenue Next 3Y 1.9% Revenue Next 5Y 0.85%
EBIT growth 1Y 13.41% EBIT growth 3Y 17.59%
EBIT growth 5Y 11.78% EBIT Next Year 44.94%
EBIT Next 3Y 15.39% EBIT Next 5Y 12.21%
FCF growth 1Y 64.09% FCF growth 3Y 24.42%
FCF growth 5Y 19.85% OCF growth 1Y 34.4%
OCF growth 3Y 13.83% OCF growth 5Y 13.94%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA